XNK Therapeutics
Hans-Gustaf Ljunggren (MD, PhD) serves as a Professor at Karolinska Institutet and is the Founder of the Centre for Infectious Medicine (CIM) and former Dean of Research at Karolinska Institutet. He has a long background in NK cell-related research, including NK cell-based cancer immunotherapy. Since 2020, he is the Director of the Vinnova Competence Center NextGenNK, focusing on the development of next-generation NK cell-based immunotherapies. He serves on several boards and SABs in the area of cancer immunotherapy. He is a member of the Nobel Assembly of Karolinska Institutet.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
XNK Therapeutics
XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.